Y-MABS THERAPEUTICS INC's ticker is YMAB and the CUSIP is 984241109. A total of 94 filers reported holding Y-MABS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $187,676 | -22.6% | 34,436 | -3.6% | 0.00% | – |
| Q2 2023 | $242,511 | -43.4% | 35,716 | -58.2% | 0.00% | – |
| Q1 2023 | $428,129 | +279.4% | 85,455 | +269.6% | 0.00% | – |
| Q4 2022 | $112,841 | -92.4% | 23,123 | -77.7% | 0.00% | – |
| Q3 2022 | $1,494,000 | +43.4% | 103,586 | +50.3% | 0.00% | – |
| Q2 2022 | $1,042,000 | -78.0% | 68,907 | -82.7% | 0.00% | – |
| Q1 2022 | $4,738,000 | +256.8% | 398,823 | +386.8% | 0.00% | – |
| Q4 2021 | $1,328,000 | -42.0% | 81,925 | +2.1% | 0.00% | – |
| Q3 2021 | $2,290,000 | -18.0% | 80,264 | -2.8% | 0.00% | – |
| Q2 2021 | $2,791,000 | +11.8% | 82,570 | +0.0% | 0.00% | – |
| Q1 2021 | $2,497,000 | -17.0% | 82,568 | +35.9% | 0.00% | – |
| Q4 2020 | $3,009,000 | +8.6% | 60,767 | -15.8% | 0.00% | – |
| Q3 2020 | $2,770,000 | -7.5% | 72,170 | +4.1% | 0.00% | – |
| Q2 2020 | $2,994,000 | +69.7% | 69,311 | +2.5% | 0.00% | – |
| Q1 2020 | $1,764,000 | -34.6% | 67,597 | -21.7% | 0.00% | – |
| Q4 2019 | $2,699,000 | +76.1% | 86,382 | +46.8% | 0.00% | – |
| Q3 2019 | $1,533,000 | +247.6% | 58,844 | +205.6% | 0.00% | – |
| Q2 2019 | $441,000 | +37.4% | 19,258 | +57.8% | 0.00% | – |
| Q1 2019 | $321,000 | +163.1% | 12,204 | +102.4% | 0.00% | – |
| Q4 2018 | $122,000 | +2340.0% | 6,029 | +3056.5% | 0.00% | – |
| Q3 2018 | $5,000 | – | 191 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 191,176 | $1,041,909 | 4.24% |
| Sofinnova Investments, Inc. | 2,194,278 | $11,958,815 | 0.75% |
| DENALI ADVISORS LLC | 85,900 | $468,155 | 0.16% |
| Polar Capital Holdings Plc | 2,103,298 | $11,462,974 | 0.08% |
| Soleus Capital Management, L.P. | 157,182 | $856,642 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 137,299 | $748 | 0.06% |
| Caligan Partners LP | 23,321 | $127,099 | 0.06% |
| Corton Capital Inc. | 12,244 | $66,730 | 0.03% |
| RICE HALL JAMES & ASSOCIATES, LLC | 91,249 | $497,307 | 0.03% |
| CIM INVESTMENT MANAGEMENT INC | 15,313 | $83,456 | 0.03% |